BOSTON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-CD3 ...
Brain-derived extracellular vesicle (EV) biomarkers represent a promising frontier for liquid biopsy development targeting the nervous system. They offer strong potential for enabling minimally ...
With few biomarkers for early identification and limited therapy options for conditions such as Alzheimer's disease (AD) and Parkinson's disease (PD), there is an urgent need for further information ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results